Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen vs Lidocaine for Mammography Pain
NCT02801786Phase 3Unknown
- Sponsor
- Universidade Federal de Goiás
- Start
- Nov 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tamoxifen, lidocaine 10% oropharyngeal spray in mastalgia, procedural pain, sponsored by Universidade Federal de Goiás. Status: unknown.
02
Drugs
tamoxifenlidocaine 10% oropharyngeal spray
03
Conditions
mastalgiaprocedural pain
Beyond the preview
Go deeper on NCT02801786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801786.